Initial experience of using an iron-containing fiducial marker for radiotherapy of prostate cancer: Advantages in the visualization of markers in Computed Tomography and Magnetic Resonance Imaging

[1] Chan MF, Cohen GN, Deasy JO. Qualitative evaluation of fiducial markers for radiotherapy imaging. Technol Cancer Res Treat. 2015;14(3):298-304.10.1177/1533034614547447Search in Google Scholar

[2] Ng M, Brown E, Williams A, et al. Fiducial markers and spacers in prostate radiotherapy: current applications. BJU Int. 2014;113(S2):13-20.10.1111/bju.12624Search in Google Scholar

[3] Gurney-Champion OJ, Lens E, van der Horst A, et al. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Med Phys. 2015;42(5):2638-2647.10.1118/1.4918753Search in Google Scholar

[4] Tanaka O, Hayashi S, Matsuo M, et al. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;66(2):597-602.10.1016/j.ijrobp.2006.06.023Search in Google Scholar

[5] Tanaka O, Hattori M, Hirose S. Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancer. Radiother Oncol. 2016;119(Supplement1):S858-S859.10.1016/S0167-8140(16)33081-XSearch in Google Scholar